Mönckeberg's sclerosis – is the artery the only target of calcification?
© Couri et al; licensee BioMed Central Ltd. 2005
Received: 25 April 2005
Accepted: 12 December 2005
Published: 12 December 2005
Since its first description, Mönckeberg's sclerosis has only been related to arterial media calcification, being listed among the primary diseases of the vessels.
We report here a clinically and histologically confirmed case of Mönckeberg's sclerosis in which the patient presented with massive areas of soft tissue calcifications in the pharynx and larynx. Polysomnographic parameters showed severe obstructive apnea refractory to nasal continuous positive airway pressure. Clinical and laboratory findings excluded concomitant endocrine or rheumatological diseases.
Our data provide a new insight about Mönckeberg's sclerosis, i.e., the fact that the etiopathogenic process involved in the phenomenon of calcification may not be restricted only to the arteries, but may occur in the entire organism. Further studies of the etiopathogenesis of this disease are needed.
Mönckeberg's sclerosis (MS) is a degenerative and apparently non-inflammatory disease in which the media of small and medium-sized muscular arteries becomes calcified independently of atherosclerosis. Since the condition does not involve primarily the intimal layer of the artery, the lumen is kept open by the rigid media and, therefore, luminal narrowing is not a direct consequence [1–4]. Recent studies, however, have demonstrated that MS is a risk factor for cardiovascular disease and peripheral artery obstruction [1, 4, 5]. The exact etiopathogenesis of this process is far from being understood, but is frequently related to glucose intolerance, aging, male gender, autonomic neuropathy, osteoporosis and, chronic renal failure[6, 7]. It commonly occurs in peripheral arteries of the lower limbs where it is seen as "rail tracking" on incidental plain radiographs[1, 8].
To the best of our knowledge, soft tissue calcifications have never been described in such disease, especially in association with obstructive sleep apnea (OSA). We report here a patient with classic MS who presented severe OSA due to calcinosis of the pharynx.
A 63-year-old Brazilian woman was referred to the hospital with a 20-year history of an increasing size of the anterior portion of the neck associated with progressive exertional dyspnea, nighttime snoring and coughing, dysphagia of solids and daytime sleepiness. She had no history of hypertension, cigarette smoking, alcohol ingestion, weight loss, fractures or fever. Her medical history was significant for intermittent claudication.
Physical examination showed a thin woman (body mass index of 17 kg/m2) with a hard, irregular, painless, mobile tumoration on the anterior surface of the neck. No lymph nodes were palpable and hoarseness was evident. There was no craniofacial abnormality. The results of oral cavity, thyroid, cardiopulmonary and abdominal examination were unremarkable. The femoral arteries appeared to be thickened and pulses were frail although there were no signs of acute limb ischemia.
Diagnostic values of sleep and respiratory variables obtained by polysomnography
Sleep and respiratory variables
Sleep efficiency (TST*/TRT† %)
Stage 1 (%)
Stage 2 (%)
Stage 3–4 (%)
Stage REM (%)
Mean oxygen saturation(%)
Minimal oxygen saturation (%)
Apnea/Hypopnea index (/hour)
Apnea index (/hour)
Mean duration of apneas (seconds)
Time spent with SaO2 <90%(min)
Continuous positive airway pressure (CPAP) tritation for treatment of such obstructive sleep apnea has been tried twice on different occasions, but the patient has complained of extreme discomfort (she could hardly sleep during the procedures). A pressure of 10 cm H2O was reached during some short periods of sleep with a very low effect on the frequency of episodes of apnea. So, with the aim of stopping further vascular and soft tissue calcification, intravenous dissodic pamidronate was administred (60 mg IV diluted in 250 mL of saline solution once a day for 1 day).
Mönckeberg's sclerosis commonly occurs in otherwise healthy elderly patients independently of atherosclerosis. After 35 years of disease, 94% of all diabetic patients present arterial calcification. This is usually an incidental finding during lower limb radiographic examination, although involvement of renal and coronary vessels has been described . The cause of medial calcinosis remains unclear, but some insights into the etiopathogenic process have been provided by isolated studies. Shanahan el al  proposed that a loss of expression of certain proteins related to the inhibition of calcification could be the causative factor. These proteins are Gla protein, osteoprotegerin, fibrillin I and carbonic anhydrase (all produced by vascular smooth muscle cells). Byts et al.  pointed out that medial calcification can be a consequence of various metabolic changes triggered by a necrobiotic injury installed in the vessel wall.
Since its first description in 1903 , MS has only been related to media calcification of small-to-medium-sized arteries, being listed among the primary diseases of the vessels. Calcic involvement of soft tissues has never been described in MS patients. In our case the pharynx involvement was strong enough to produce severe obstructive sleep apnea and the symptoms were clearly associated with the massive tumoral growth of the anterior portion of the neck.
Obstructive sleep apnea results from repetitive episodes of pharyngeal occlusion during sleep which reverse with arousal, thus inducing sleep fragmentation, a low amount of slow wave sleep (stages 3 and 4 non-REM sleep) and a low amount of REM sleep with consequent daytime somnolence . Sleep apnea causes repetitive episodes of hypoxia, hypercapnia and reoxigenation that can lead to a variety of physiological processes including pulmonary hypertension and other vascular consequences. Our patient had a confirmed increase in pulmonary arterial pressure that could not be entired explained by the OSA syndrome. Probably it has been worsened by the concomitant left ventriculat disfunction. The exact cause of the cardiac disfunction could not be widely investigated, but OSA is an important contributor.
Generally, the pathogenesis of upper airway obstruction involves anatomic and neurological components. Obesity, age, male sex, positive family history and alcohol consumption are well known as major risk factors for this disorder in adults. Narrowing may occur at one or more sites in an unstable upper airway due to anatomical partial obstruction as a result of developmental delay, craniofacial abnormalities and neurologic diseases. Our patient was a non-alcoholic, very slim woman (as judged by a body mass index of 17 kg/m2) with no family history of similar disorders.
The massive calcification areas of the pharynx were confirmed by radiological images, laryngoscopic visualization and a biopsy of the exophytic lesion in the pyriform sinus which revealed areas of soft tissue calcification. We excluded metastatic and dystrophic calcification in the light of the histological appearance of the lesion and the absence of malignancy and of rheumatologic or endocrine diseases.
A lower limb X-ray evidenced the classic "rail tracking" appearance of MS described by other authors [1, 4] and a temporal artery biopsy confirmed the intense media calcinosis. The concomitant atherosclerotic process involving the intima layer of the femoral arteries explained the intermittent claudication and weak pulses presented by this patient. Both OSA and MS are recognized as causative factors of atherosclerosis[1, 13]. Additionally, our patient presented low bone mineral density, and this finding supports recent evidences showing association between arterial calcification and osteoporosis[14, 15].
As can be seen in figure 3, the amount of airway obstruction caused by the grossly calcified tissue could be the answer for the discomfort related to CPAP titration. In face of the difficulties related to this approach, tracheostomy was thought to solve this problem. However, the risk of triggering even more tissue calcification secondary to tissue damages discouraged the realization of this procedure.
Alternatively, treatment with intravenous dissodic pamidronate was attempted to stop the phenomenon of calcification and prevent further airway obstruction. This drug has the property to attach to hydroxyapatite crystals preventing both vascular and soft tissue calcification. Additionally, it worked as a treatment for osteoporosis presented by the patient.
Although one can argue about the possible role of upper airway obstruction in intensifying the local deposition of calcium in the soft tissue of the pharynx, the diagnosis of MS was well documented in this case. The present report provides a new insight about this disease, i.e., the fact that the etiopathogenic process involved in the phenomenon of calcification may not be restricted only to the arteries, but may involve the entire organism.
Monckeberg's sclerosis is a primary disease of the arteries. However, the present case report raises extensive questions about the etiopathogenic process involved in MS, since this is the first report of soft tissue calcification related to this disease. Further investigations of the etiology and pathogenesis of this disease are needed.
We thank Mrs. E. Greene for revision of the English text. We also thank the patient for giving us a written consent for publishing his case. This case report was supported by FAEPA.
- Top C, Çankir Z, Şilit E, Silit E, Yildirim S, Danaci M: Mönckeberg's sclerosis: an unusual presentation. Angiology. 2002, 53: 483-86.View ArticlePubMedGoogle Scholar
- Shoi A, Taniwaki H, Jono S, Okuno Y, Koyama H, Mori K, Nishizawa Y: Mönckeberg's Medial Sclerosis and Inorganic Phosphate in Uremia. Am J Kidney Dis. 2001, 47-49. Suppl 1Google Scholar
- Mönckeberg JG: Uber die reine Mediaverkalkung der Extremitätenarterien und ihr verhalten zur Arteriosklerose. Virchows Arch Pathol Anat. 1903, 171: 141-67. 10.1007/BF01926946.View ArticleGoogle Scholar
- Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC: Medial Calcinosis of Mönckeberg. Am J Med. 1977, 63: 615-22. 10.1016/0002-9343(77)90207-8.View ArticlePubMedGoogle Scholar
- Lehto S, Niskanen L, Suhonen M, et al: Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996, 16: 978-83.View ArticlePubMedGoogle Scholar
- Goebel FD, Füessl HS: Mönckeberg's sclerosis after sympatect denervation in diabetic and non-diabetic subjects. Diabetologia. 1983, 24: 347-50. 10.1007/BF00251822.View ArticlePubMedGoogle Scholar
- Amos RS, Wright V: Monckeberg's Arteriosclerosis and Metabolic Bone Disease. Lancet. 1980, 2: 248-9. 10.1016/S0140-6736(80)90133-6.View ArticlePubMedGoogle Scholar
- Silbert S, Lippmann HI: Mönckeberg's arterioclerosis. JAMA. 1955, 151: 1176-79.View ArticleGoogle Scholar
- White P: Natural course and prognosis of juvenile diabetes:. Diabetes. 1956, 5: 445-50.View ArticlePubMedGoogle Scholar
- Shanahan C, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Mönckeberg sclerosis. Circulation. 1999, 100: 2168-76.View ArticlePubMedGoogle Scholar
- Byts IUV, Holdobina VIE, Dudko MO: The current concepts of the pathogenesis of Monckeberg-type arteriosclerosis. Fiziol Zh. 2000, 46: 64-72.PubMedGoogle Scholar
- Peter JH, Koehler U, Grote L, Podszus T: Manifestations and consequences of obstructive sleep apnoea. Eur Respir J. 1995, 8: 1572-1583.PubMedGoogle Scholar
- Strollo PJ, Rogers RM: Obstructive sleep apnea. N Engl J Med. 1996, 334: 99-104. 10.1056/NEJM199601113340207.View ArticlePubMedGoogle Scholar
- Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V: Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrino Metab. 2004, 89: 4246-53. 10.1210/jc.2003-030964.View ArticleGoogle Scholar
- Rubin MR, Silverberg SJ: Vascular calcification and osteoporosis – the nature of the nexus. J Clin Endocrinol Metab. 2004, 89: 4243-45. 10.1210/jc.2004-1324.View ArticlePubMedGoogle Scholar
- Ono K, Wada S: Regulation of calcification by bisphosphonates. Clin Calcium. 2004, 14: 60-63.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/5/34/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.